Bioluminescence-triggered photocatalytic labeling

Patent metadata

Field	Value
Publication number	US-2024191211-A1
Application number	US-202318312487-A
Country	US
Kind code	A1
Filing date	May 4, 2023
Priority date	May 4, 2022
Publication date	Jun 13, 2024
Grant date	—

Abstract

Provided herein are systems, methods, and compositions for bioluminescence-triggered catalysis of bioorthogonal labeling chemistries in a proximity dependent manner. In particular, provided herein are bioluminescent proteins or complexes, luminophore substrates thereof, photocatalysts or photosensitizers, activatable labels, and systems thereof, and methods of catalytically activating the activatable labels via bioluminescence-triggered catalysis.

First claim

1 . A system comprising:
(a) (i) a bioluminescent protein having at least 70% sequence identity with SEQ ID NO: 1 or a circularly permuted variant thereof or (ii) structurally-complementary components of a bioluminescent complex wherein the structurally-complementary components collectively comprise at least 70% sequence identity with SEQ ID NO: 2; (b) a coelenterazine luminophore or a derivative thereof, wherein the bioluminescent protein or complex catalyzes emission of a first wavelength of light from the luminophore upon interaction therewith; (c) a photocatalyst, wherein the photocatalyst is activated by exposure to light of the first wavelength; and (d) an activatable label, wherein the activatable label is converted into an activated label when in proximity to the activated photocatalyst.

2 - 19 . (canceled)

20 . The system of claim 1 , wherein the coelenterazine luminophore is furimazine or fluorofurimazine.

21 . (canceled)

22 . The system of claim 1 , wherein the photocatalyst is of the structure of Formula (I):

wherein:
each set of dashed lines ( ) represents the presence or absence of a fused 6-membered ring;
M is a transition metal;
m1, m2, m3, n1, n2, n3, p1, p2, and p3 are each independently 0, 1, or 2;
R 1a , R 1b , R 1c , R 2a , R 2b , R 2c , R 3a , R 3b , and R 3c are each independently selected from halo, alkyl, haloalkyl, amino, heteroalkyl, and a group -Linker-Q, wherein Q is a capture element;
X 1a , X 1b , X 2a , X 2b , X 3a , and X 3b are each independently selected from N and C, wherein at least one of X 1a and X 1b is N, at least one of X 2a and X 2b is N, and at least one of X 3a and X 3b is N;
X 1c , X 1d , X 2c , X 2d , X 3c , and X 3d are each independently selected from CH and N;
Z is an anion; and
q is 0, 1, or 2.

23 . (canceled)

24 . The system of claim 22 , wherein the photocatalyst is an iridium-based photocatalyst selected from:

or a ruthenium-based photocatalyst selected from:

or a derivative thereof in which the compound is functionalized with at least one group -Linker-Q, wherein Q is a capture element.

25 . (canceled)

26 . The system of claim 22 , wherein the photocatalyst is of the formula:

27 . The system of claim 22 , wherein one of R 1a , R 1b , R 1c , R 2a , R 2b , R 2c , R 3a , R 3b and R 3c is a group -Linker-Q, wherein Q is a haloalkane capture element.

28 - 29 . (canceled)

30 . The system of claim 27 , wherein the Linker comprises ester (—C(O)O—), amide (—C(O)NH—), carbamate (—NHC(O)O—), urea (—NHC(O)NH—), phenylene, straight or branched chain alkylene, oligo- or poly-ethylene glycol (—(CH 2 CH 2 O) x —), or combinations thereof.

31 . (canceled)

32 . The system of claim 30 , wherein the Linker is selected from:

33 . (canceled)

34 . The system of claim 1 , wherein the photocatalyst is an organic photoredox catalyst, wherein the organic photoredox catalyst is selected from a quinone, a pyrylium, an acridinium, and a xanthene.

35 . The system of claim 34 , wherein the organic photoredox catalyst is a quinone selected from:

36 . The system of claim 34 , wherein the organic photoredox catalyst is a pyrylium selected from:

37 . The system of claim 34 , wherein the organic photoredox catalyst is an acridinium selected from:

38 . The system of claim 34 , wherein the organic photoredox catalyst is a xanthene selected from:

39 . The system of claim 34 , wherein the organic photoredox catalyst is a thiazine-based organic photoredox catalyst.

40 - 44 . (canceled)

45 . The system of claim 1 , wherein the activatable label comprises a fluorogenic dye, capture agent, cleavable capture agents as well as click handle.

46 . The system of claim 1 , wherein the activatable label comprises a photoreactive group and a functional group.

47 . The system of claim 46 , wherein upon activation of the photoreactive group by the photocatalyst or photosensitizer, the activated label binds covalently to a target molecule.

48 . The system of claim 47 , further comprising a target molecule that the activated label is capable of reacting with.

49 - 50 . (canceled)

51 . The system of claim 46 , wherein the photoreactive group comprises:
(a) an activatable benzoyl azide variant is selected from:

wherein R is selected from H, Cl, F, Br, I, CH 3 , OH, SH, NH 2 , CN, CF 3 , CCl 3 , CH═CH 2 , —CH 2 —CH 3 , —CH 2 —OH, —CH 2 NH 2 , CH 2 SH, CH 2 Cl, CH 2 Br, CH 2 F, CHF 2 , CH 2 CN, CH 2 CF 3 , CH 2 Cl 3 , O—CH 3 , C(O)CH 3 , C(O)OH, and C(O)NH 2 ; and
wherein X is O or S;
(b) an activatable benzyl diazirine variant is selected from:

wherein R is selected from H, Cl, F, Br, I, CH 3 , OH, SH, NH 2 , CN, CF 3 , CCl 3 , CH═CH 2 , —CH 2 —CH 3 , —CH 2 —OH, —CH 2 NH 2 , CH 2 SH, CH 2 Cl, CH 2 Br, CH 2 F, CHF 2 , CH 2 CN, CH 2 CF 3 , CH 2 Cl 3 , O—CH3, C(O)CH 3 , C(O)OH, and C(O)NH 2 ;

(2 aryl-5-carboxyterazole (ACT)); or an ACT derivative; wherein R is selected from H, Cl, F, Br, I, CH 3 , OH, SH, NH 2 , CN, CF 3 , CCl 3 , CH═CH 2 , —CH 2 —CH 3 , —CH 2 —OH, —CH 2 NH 2 , CH 2 SH, CH 2 Cl, CH 2 Br, CH 2 F, CHF 2 , CH 2 CN, CH 2 CF 3 , CH 2 Cl 3 , O—CH 3 , C(O)CH 3 , C(O)OH, and C(O)NH 2 ;

wherein one of R1-R3 is a linkage to the rest of the activatable moiety and the other two of R1-R3 are independently selected from H, Cl, F, Br, I, CH 3 , OH, SH, NH 2 , CN, CF 3 , CCl 3 , CH═CH 2 , —CH 2 —CH 3 , —CH 2 —OH, —CH 2 NH 2 , CH 2 SH, CH 2 Cl, CH 2 Br, CH 2 F, CHF 2 , CH 2 CN, CH 2 CF 3 , CH 2 Cl 3 ,

Assignees

• Promega Corp

Inventors

• Ohana Rachel Friedman
• Shi Ce
• Hurst Robin
• Klein Mark A
• Cao Jian
• Kirkland Thomas
• Fitzgerald Connor
• Uyeda Tetsuo
• Machleidt Thomas
• Zhou Wenhui
• Larsen Matthew A
• Wang Hui
• An Weiwei
• Porter Karilyn

Classifications

• C12Y113/12013

  Oplophorus-luciferin 2-monooxygenase (1.13.12.13) · CPC title

• C12N9/0069 Primary

  acting on single donors with incorporation of molecular oxygen, i.e. oxygenases (1.13) · CPC title

• B01J31/2295

  Cyclic compounds, e.g. cyclopentadienyls · CPC title

• B01J35/39

  Photocatalytic properties · CPC title

• C07B2200/05

  Isotopically modified compounds, e.g. labelled · CPC title